NCT06263127

Brief Summary

Preterm infants experiencing bottle feeding difficulties will be included in this study. Two distinct interventions, oral stimulation (OS) and infant massage (IM), will be administered in this study. The objective of this clinical trial is to compare the effectiveness of these two approaches, either individually or in combination, in improving the feeding performance and development of participants.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 16, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

February 20, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2026

Completed
Last Updated

February 16, 2024

Status Verified

February 1, 2024

Enrollment Period

1.9 years

First QC Date

January 10, 2024

Last Update Submit

February 14, 2024

Conditions

Keywords

NICUMassagePreterm infantsoral stimulation

Outcome Measures

Primary Outcomes (2)

  • Oral intake

    The volume of oral intake in the feeding

    the 1st, 8th, and 14th day of the intervention period

  • Transition time of oral feeding

    the number of days from the first day of the intervention to the day at full oral feeding

    from the date of the first day of the intervention until the date of full oral feeding, assesed up to 4 weeks

Secondary Outcomes (5)

  • weight gain

    14 days

  • Hospital stay

    from the date of the first day of the intervention until the date of hospital discharge, assessed up to 6 weeks

  • Neonatal Neurobehavioral Examination-Chinese Version(NNE-C)

    the 1st and 14th day of the intervention period

  • Infant/Toddler Sensory Profile-Chinese Version(ITSP-C)

    conducted at around 3 months of corrected age

  • Premature Bottle Feeding Questionnaire(PBFQ)

    conducted at around 3 months old of corrected age

Study Arms (2)

OS group

EXPERIMENTAL

The participants receive the prefeeding oral stimulation intervention twice a day,10 days.

Behavioral: oral stimulation

OS+ IM group

EXPERIMENTAL

The participants receive both prefeeding oral stimulation and infant massage once a day, in random order, 10 days.

Behavioral: oral stimulationBehavioral: infants massage

Interventions

Prefeeding OS is a 5-minute oral sensorimotor intervention, containing peri- and intra-oral stimulation for 3 minutes and pacifier sucking for 2 minutes.

Also known as: oral sensoriomotor stimulation
OS groupOS+ IM group
infants massageBEHAVIORAL

IM is a 15-minute intervention, involving 5-min manual stroking on the infant's head, neck, back, upper limbs, and lower limbs twice and 5-min gentle flexion and extension exercises on the infant's arms and legs.

Also known as: body massage
OS+ IM group

Eligibility Criteria

AgeUp to 34 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • \< 34 weeks' gestational age
  • \~40 weeks' postmenstrual age at enrollment
  • being fed by oral for at least 2 days but with poor feeding performance defined as consuming less than 80% of the prescribed volume for the half or more feedings
  • weaning the ventilator and maintaining stable physiological status

You may not qualify if:

  • Congenital anomalies
  • Confirmed or suspected chromosomal or genetic abnormalities
  • Unsolved seizure, sepsis, necrotizing enterocolitis(NEC)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospital

Taichung, 404, Taiwan

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2024

First Posted

February 16, 2024

Study Start

February 20, 2024

Primary Completion

January 10, 2026

Study Completion

January 10, 2026

Last Updated

February 16, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations